Recruiting
TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate
NCT06513286
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
- Locations
-
- Investigational Site GUF Frankfurt, Germany
- Investigational Site UKE Hamburg, Germany
- Investigational Site MHH Hanover, Germany
- Investigational Site Uni Leipzig Leipzig, Germany